Treatment with pembrolizumab in programmed death ligand 1–positive recurrent glioblastoma: Results from the multicohort phase 1 KEYNOTE‐028 trial.
Saved in:
| Title: | Treatment with pembrolizumab in programmed death ligand 1–positive recurrent glioblastoma: Results from the multicohort phase 1 KEYNOTE‐028 trial. |
|---|---|
| Authors: | Reardon, David A.1 (AUTHOR) david_reardon@dfci.harvard.edu, Kim, Tae Min2 (AUTHOR), Frenel, Jean‐Sebastien3 (AUTHOR), Simonelli, Matteo4,5 (AUTHOR), Lopez, Juanita6 (AUTHOR), Subramaniam, Deepa S.7 (AUTHOR), Siu, Lillian L.8 (AUTHOR), Wang, Hui9 (AUTHOR), Krishnan, Suba10 (AUTHOR), Stein, Karen10 (AUTHOR), Massard, Christophe11 (AUTHOR) |
| Source: | Cancer (0008543X). May2021, Vol. 127 Issue 10, p1620-1629. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 150065066 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Treatment with pembrolizumab in programmed death ligand 1–positive recurrent glioblastoma: Results from the multicohort phase 1 KEYNOTE‐028 trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Reardon%2C+David+A%2E%22">Reardon, David A.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> david_reardon@dfci.harvard.edu</i><br /><searchLink fieldCode="AR" term="%22Kim%2C+Tae+Min%22">Kim, Tae Min</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Frenel%2C+Jean‐Sebastien%22">Frenel, Jean‐Sebastien</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Simonelli%2C+Matteo%22">Simonelli, Matteo</searchLink><relatesTo>4,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lopez%2C+Juanita%22">Lopez, Juanita</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Subramaniam%2C+Deepa+S%2E%22">Subramaniam, Deepa S.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Siu%2C+Lillian+L%2E%22">Siu, Lillian L.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Hui%22">Wang, Hui</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Krishnan%2C+Suba%22">Krishnan, Suba</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Stein%2C+Karen%22">Stein, Karen</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Massard%2C+Christophe%22">Massard, Christophe</searchLink><relatesTo>11</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Cancer+%280008543X%29%22">Cancer (0008543X)</searchLink>. May2021, Vol. 127 Issue 10, p1620-1629. 10p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=150065066 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cncr.33378 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 10 StartPage: 1620 Titles: – TitleFull: Treatment with pembrolizumab in programmed death ligand 1–positive recurrent glioblastoma: Results from the multicohort phase 1 KEYNOTE‐028 trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Reardon, David A. – PersonEntity: Name: NameFull: Kim, Tae Min – PersonEntity: Name: NameFull: Frenel, Jean‐Sebastien – PersonEntity: Name: NameFull: Simonelli, Matteo – PersonEntity: Name: NameFull: Lopez, Juanita – PersonEntity: Name: NameFull: Subramaniam, Deepa S. – PersonEntity: Name: NameFull: Siu, Lillian L. – PersonEntity: Name: NameFull: Wang, Hui – PersonEntity: Name: NameFull: Krishnan, Suba – PersonEntity: Name: NameFull: Stein, Karen – PersonEntity: Name: NameFull: Massard, Christophe IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 05 Text: May2021 Type: published Y: 2021 Identifiers: – Type: issn-print Value: 0008543X Numbering: – Type: volume Value: 127 – Type: issue Value: 10 Titles: – TitleFull: Cancer (0008543X) Type: main |
| ResultId | 1 |